We are Sorry, This Page doesn't Exist

Shares of Proteostasis Therapeutics Inc. fell 35% in premarket trading on Tuesday after the biopharmaceutical company shared mixed findings from a mid-stage study for its experi.....»»

Shares of biotech Intra-Cellular Therapies fell 15% in premarket trade Monday after the company announced disappointing results from a late-stage trial of its lead drug candidate lumateperone,.....»»

Shares of the thinly traded small-cap biotech Savara Inc (NASDAQ: SVRA) were plunging to a record low Thursday in the wake of a clinical trial readout from the company. read more.....»»

Gilead Sciences Inc. shares fell 4% in the extended session Monday after the pharma company said a late-stage, placebo-controlled study des.....»»

The company said late-stage nonalcoholic steatohepatitis drug selonsertib didn’t meet its primary endpoint......»»

Incyte Corp. said Friday it and Novartis AG started a late-stage clinical trial to study a drug meant to treat a serious complication of COVID-19. The biotech company said it was testin.....»»

Biotech giant Genentech Inc. is working with federal agencies to start a late-stage clinical trial in early April of its already-approved rheumatoid arthritis drug Actemra against the virus that causes COVID-19. The South San Francisco company said th.....»»

Acceleron Pharma Inc. shares surged in the extended session late Monday after the biotech drug maker said its hypertension drug hit key goals in a mid-stage clinical trial. Acceleron shares soared 56%.....»»

Progenics Pharmaceuticals, Inc. said Monday a late-stage trial of a treatment for prostate cancer met.....»»

A set of conclusive findings from a late-stage clinical trial testing ChemoCentryx Inc.’s experimental vasculitis treatment surprised company executives and investors, who now say they are bullish on the sales and pipeline potential of avacopan......»»

Myovant Sciences Ltd. shares soared 79% in premarket trade Tuesday, after the healthcare company said a late-stage trial of a treatment for advance.....»»

Myovant Sciences Ltd. shares soared 37% in premarket trade Tuesday, after the healthcare company said a late-stage trial of a treatment for advance.....»»

Shares of Biogen Inc. fell 1.6% in premarket trading Friday, after the the biotechnology company and Tokyo-based Eisai Co. Ltd. said they will discontinue the phase 3 trial of an Alzheimer's disease.....»»

Shares of Acadia Pharmaceuticals Inc. rocketed 87% toward a 4-year high in premarket trading Monday, after the biopharmaceutical company said a phase 3 trial of its treatment for dementia-related psychosis met its primary endpoint. Th.....»»

Micro-cap Intec Pharma Ltd (NASDAQ: NTEC) shares are plummeting on heavy volume Monday following a clinical trial readout from the company.....»»

Unum Therapeutics Inc (NASDAQ: UMRX) shares were under pressure Wednesday following a clinical trial update provided by the company late Tuesday. read more.....»»

Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares are advancing strongly Tuesday following the release of the results of a late-stage study of its drug candidate for allergic conjunctivitis. Latest R.....»»

Six years after starting its first clinical trial, a small San Francisco company hopes that moving its pain treatment into a late-stage trial will generate a fundraising buzz but no excitement for pain-drug addicts. Adynxx Inc. said Thursday that i.....»»

Shares of AbbVie Inc. jumped 2.2% in premarket trade Monday, after the company reported positive results in a late-stage trial of a treatment for rheumatoid arthritis. AbbVie said the phase 3 trial of upadacitinib met its primary endpoints. Upadaciti.....»»

Proteostasis Therapeutics saw its shares slide early on Thursday after the company reported positive data from its early stage trial in cystic fibrosis......»»